Viltepso (Viltolarsen)

  • Brand Name: Viltepso
  • Innovator Brand Name: Viltepso
  • API: Viltolarsen
  • Dosage Form: 1 Vial (Per Box)
  • Strength: 250 mg/5mL
  • Manufacturer Name: NS Pharma, Inc.
Get Price


Viltolarsen Uses

Viltepso (Viltolarsen 250 mg) injection is an antisense oligonucleotide used for the treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 53 skipping.

Dosage: The recommended dose of Viltolarsen is 80 mg/kg administered once weekly as a 60 minute intravenous infusion. If a viltolarsen 250mg injection dose is missed, it should be administered as soon as possible after the scheduled dose time. Serum cystatin C, urine dipstick, and urine protein-to-creatinine ratio should be assessed prior to initiating Viltolarsen injection therapy. Consider measurement of glomerular filtration rate prior to initiation of Viltepso injection treatment. Monitoring for kidney toxicity during therapy is recommended.

Side Effects: The most commonly reported viltolarsen side effects (incidence ≥15%) include:

  • Cough
  • Pyrexia
  • Injection site reaction
  • Upper respiratory tract infection

Warnings and Precautions:

  • Inform each of your health specialists about all your medical conditions, allergies, and all medicines you use.
  • During treatment with Viltepso 250 mg Injection, monitor urine dipstick every month, and serum cystatin C and urine protein-to-creatinine ratio every three months.
  • Patients with known renal function impairment should be precisely monitored while on treatment with Viltepso injection.
  • Your healthcare professional will perform blood tests to make sure you do not have conditions that would prevent you from safely using viltepso 250 mg injection.

More info

Storage: Store Viltolarsen injection at 2°C to 8°C (36°F to 46°F). It is not recommended to freeze this medication. Availability in India: The Indian Pharma helps connect buyers with suppliers who can ship the VILTEPSO at the global level as per the needs of buyer’s. The Indian Pharma provides guarantee of quality as well as delivery for the VILTEPSO Injections. Buying Procedure: In order to buy VILTEPSO, you can contact us at our TOLL-FREE Number 1800 889 1064 or on WhatsApp Number +919310090915 or an Email to us at: along with the legitimate ID Proof, standard Prescription and Medical Reports. Conclusions: Viltolarsen treatment in patients with Duchenne muscular dystrophy who are amenable to exon 53 skipping resulted in significant increases in dystrophin production. Timed function tests provided supportive evidence of treatment-related clinical improvement. The adverse events were mild to moderate. No serious adverse events were reported and there were no discontinuations from the study.


What is Viltepso? Viltepso is specifically a morpholino antisense oligonucleotide, intended to treat patients with DMD (Duchenne Muscular Dystrophy). What does Viltepso contain as an active substance? The medication Viltepso specifically contains the active substance Viltolarsen. How much medication is in each Viltepso dosage? Your health specialist will calculate the dosage based on your child’s body weight. 80 mg of Viltepso is administered for each kilogram (a kilogram is approximately 2.2 pounds) of your child’s weight per week. How is Viltolarsen supplied? Viltolarsen is a clear and colorless solution supplied as Injection: 250 mg/5 mL (50 mg/mL) solution in a single-dose vial. How much does viltepso cost? The viltepso price in India usually can vary depending on the wholesaler/pharmacy you visit. Viltepso is available as a brand name drug only, a generic version is not yet available. What is the best price for Viltolarsen? Please contact Toll-free: +91 1800 889 1064|+919310090915 for viltolarsen price in India. We take the guarantee of quality and delivery anywhere in the world as per the buyer’s requirements. Can I get Viltepso (Viltolarsen) even if I am not based in India? The Indian Pharma helps patients in accessing or importing Viltepso (Viltolarsen), not approved in their home country against the legitimate prescription and in conformity with the all local laws and regulations of their home country.